Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Tax Withholding of 8,724 TRDA shares, $62.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Entrada Therapeutics, Inc. (TRDA) | Tax Withholding | 8,724 | $62.3K |
| Mar 3, 2026 | Entrada Therapeutics, Inc. (TRDA) | Grant/Award | 139,400 | n/a |
| Feb 6, 2026 | Azenta, Inc. (AZTA) | Grant/Award | 5,663 | $157.7K |
| Sep 4, 2025 | Entrada Therapeutics, Inc. (TRDA) | Tax Withholding | 8,723 | $47.4K |
| Mar 4, 2025 | Entrada Therapeutics, Inc. (TRDA) | Grant/Award | 116,200 | n/a |
| Feb 11, 2025 | Azenta, Inc. (AZTA) | Grant/Award | 4,040 | $211.4K |
| Sep 5, 2024 | Entrada Therapeutics, Inc. (TRDA) | Tax Withholding | 2,328 | $36.7K |
| Jul 16, 2024 | Entrada Therapeutics, Inc. (TRDA) | Sale | 300 | $5.4K |
| Jun 14, 2024 | Entrada Therapeutics, Inc. (TRDA) | Sale | 1,000 | $16.2K |
| May 20, 2024 | Entrada Therapeutics, Inc. (TRDA) | Sale | 1,800 | $27.0K |